Drug Stocks Viewed as ‘Deflation Immunization’: Chart of the Day
This article is for subscribers only.
Shares of drugmakers are in a position to provide investors with “deflation immunization,” according to Jonathan Glionna, head of U.S. equity strategy at Barclays Plc.
The CHART OF THE DAY illustrates how Glionna reached this conclusion, presented in a report two days ago. The chart shows growth rates in two prescription-drug spending indexes compiled by the Commerce Department and a pharmaceutical-price index put together by the Labor Department.